Pantaleo Nacci

439 total citations
9 papers, 351 citations indexed

About

Pantaleo Nacci is a scholar working on Epidemiology, Immunology and Infectious Diseases. According to data from OpenAlex, Pantaleo Nacci has authored 9 papers receiving a total of 351 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Epidemiology, 4 papers in Immunology and 2 papers in Infectious Diseases. Recurrent topics in Pantaleo Nacci's work include Influenza Virus Research Studies (4 papers), Immune Response and Inflammation (4 papers) and Respiratory viral infections research (3 papers). Pantaleo Nacci is often cited by papers focused on Influenza Virus Research Studies (4 papers), Immune Response and Inflammation (4 papers) and Respiratory viral infections research (3 papers). Pantaleo Nacci collaborates with scholars based in United States, Germany and Italy. Pantaleo Nacci's co-authors include Audino Podda, Angelika Banzhoff, Uwe Nicolay, Theodore F. Tsai, Ralf Clemens, Giovanni Della Cioppa, John Ferguson, Moe H. Kyaw, Deborah L. Novicki and P. Patriarca and has published in prestigious journals such as Vaccine, International Journal of Infectious Diseases and Gerontology.

In The Last Decade

Pantaleo Nacci

9 papers receiving 336 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pantaleo Nacci United States 8 261 117 108 51 46 9 351
J. A. Stewart United Kingdom 3 431 1.7× 142 1.2× 188 1.7× 24 0.5× 214 4.7× 6 501
Amol Chaudhari India 10 115 0.4× 21 0.2× 88 0.8× 35 0.7× 32 0.7× 11 356
Nora Dellepiane Switzerland 10 87 0.3× 18 0.2× 101 0.9× 31 0.6× 83 1.8× 18 249
Thorunn A. Olafsdottir Sweden 9 105 0.4× 149 1.3× 72 0.7× 76 1.5× 10 0.2× 13 258
Houshun Zhu Hong Kong 11 188 0.7× 146 1.2× 148 1.4× 44 0.9× 4 0.1× 11 334
Rugimar Marcovistz Brazil 12 86 0.3× 103 0.9× 144 1.3× 61 1.2× 16 0.3× 24 333
Hyunsuh Kim Australia 6 259 1.0× 92 0.8× 126 1.2× 101 2.0× 19 0.4× 9 369
Marije C. Behet Netherlands 9 40 0.2× 271 2.3× 87 0.8× 79 1.5× 51 1.1× 11 516
Ian J. Owens United Kingdom 5 218 0.8× 38 0.3× 33 0.3× 66 1.3× 5 0.1× 5 263
Robert Shaw Australia 12 368 1.4× 52 0.4× 114 1.1× 69 1.4× 6 0.1× 19 485

Countries citing papers authored by Pantaleo Nacci

Since Specialization
Citations

This map shows the geographic impact of Pantaleo Nacci's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pantaleo Nacci with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pantaleo Nacci more than expected).

Fields of papers citing papers by Pantaleo Nacci

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pantaleo Nacci. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pantaleo Nacci. The network helps show where Pantaleo Nacci may publish in the future.

Co-authorship network of co-authors of Pantaleo Nacci

This figure shows the co-authorship network connecting the top 25 collaborators of Pantaleo Nacci. A scholar is included among the top collaborators of Pantaleo Nacci based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pantaleo Nacci. Pantaleo Nacci is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Nicolay, Uwe, Esther Heijnen, Pantaleo Nacci, P. Patriarca, & Brett Leav. (2019). Immunogenicity of aIIV3, MF59-adjuvanted seasonal trivalent influenza vaccine, in older adults ≥65 years of age: Meta-analysis of cumulative clinical experience. International Journal of Infectious Diseases. 85. S1–S9. 35 indexed citations
2.
Tsai, Theodore F., Pantaleo Nacci, Uwe Nicolay, et al.. (2011). Explorations of clinical trials and pharmacovigilance databases of MF59®-adjuvanted influenza vaccines for associated cases of narcolepsy. Scandinavian Journal of Infectious Diseases. 43(9). 702–706. 72 indexed citations
3.
Black, Steven, Giovanni Della Cioppa, Anne Malfroot, et al.. (2010). Safety of MF59-adjuvanted versus non-adjuvanted influenza vaccines in children and adolescents: An integrated analysis. Vaccine. 28(45). 7331–7336. 35 indexed citations
4.
Tsai, Theodore F., Moe H. Kyaw, Deborah L. Novicki, et al.. (2009). Exposure to MF59-adjuvanted influenza vaccines during pregnancy—A retrospective analysis. Vaccine. 28(7). 1877–1880. 40 indexed citations
6.
Banzhoff, Angelika, Simonetta Viviani, A A Hoosen, et al.. (2004). Safety and immunogenicity of two Haemophilus influenzae type b conjugate vaccines.. PubMed. 94(1). 43–6. 13 indexed citations
7.
Banzhoff, Angelika, Pantaleo Nacci, & Audino Podda. (2003). A New MF59-Adjuvanted Influenza Vaccine Enhances the Immune Response in the Elderly with Chronic Diseases: Results from an Immunogenicity Meta-Analysis. Gerontology. 49(3). 177–184. 107 indexed citations
8.
Schooley, Robert T., Nathan Clumeck, Richard Haubrich, et al.. (2001). A Dose-Ranging Study to Evaluate the Antiretroviral Activity and Safety of Amprenavir Alone and in Combination with Abacavir in HIV-Infected Adults with Limited Antiretroviral Experience. Antiviral Therapy. 6(2). 89–96. 4 indexed citations
9.
Pottage, John C., H Jablonowski, William D. Hardy, et al.. (2000). Amprenavir in Combination with Lamivudine and Zidovudine versus Lamivudine and Zidovudine Alone in HIV-1-Infected Antiretroviral-Naive Adults. Antiviral Therapy. 5(3). 215–225. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026